FDA's Arista to India: What's your Everest?
This article was originally published in Scrip
Executive Summary
For the quality-hit Indian drug industry, a senior investigator from the US FDA has driven home a few candid messages – lead by example and clean up. Speaking at a conference in Mumbai, the representative pinned the responsibility on proactive corporate leadership to get the industry to follow best practices.